Crossmark

Informing future randomized controlled trials of amantadine hydrochloride in neurocritical care and post-neurocritical care stroke patients through a retrospective study

Crossref DOI link: https://doi.org/10.1186/s12883-024-03854-2

Published Online: 2024-09-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Plaitano, Enzo G. https://orcid.org/0000-0001-9701-8925
Scharf, Rebecca A.

Aboutaleb, Pakinam E.

Glennon, Andrea L.

Melkumova, Emiliya

Green-LaRoche, Deborah M.
License Information

Text and Data Mining valid from 2024-09-11

Version of Record valid from 2024-09-11
More Information

Article History

Received: 12 July 2024

Accepted: 6 September 2024

First Online: 11 September 2024

Declarations

:

: This study received ethics approval by the Tufts Medical Center Institutional Review Board (STUDY00000819) and was conducted in compliance with our institution’s HIPAA guidelines. The Tufts Medical Center Institutional Review Board waived the need for patient consent in this retrospective medical record study.

: Not Applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below